Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 165

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier

Open access
Dal Magro, R., Ornaghi, F., Cambianica, I., Beretta, S., Re, F., Musicanti, C., Rigolio, R., Donzelli, E., Canta, A., Ballarini, E., Cavaletti, G., Gasco, P., Sancini, G. · 2017 · Journal of Controlled Release

Abstract

&NA; Solid lipid nanoparticles (SLN) are colloidal drug delivery systems characterized by higher entrapment efficiency, good scalability of the preparation process and increased sustained prolonged release of the payload compared to other nanocarriers. The possibility to functionalize the surface of SLN with ligands to achieve a site specific targeting makes them attractive to overcome the limited blood‐brain barrier (BBB) penetration of therapeutic compounds. SLN are prepared for brain targeting by exploiting the adaptability of warm microemulsion process for the covalent surface modification with an Apolipoprotein E‐derived peptide (SLN‐mApoE). Furthermore, the influence of the administration route on SLN‐mApoE brain bioavailability is here evaluated. SLN‐mApoE are able to cross intact a BBB in vitro model. The pulmonary administration of SLN‐mApoE is related to a higher confinement in the brain of Balb/c mice compared to the intravenous and intraperitoneal administration routes, without inducing any acute inflammatory reaction in the lungs. These results promote the pulmonary administration of brain‐targeted SLN as a feasible strategy for improving brain delivery of therapeutics. Graphical abstract Solid lipid nanoparticles (SLN), prepared by warm microemulsion, are functionalized with a brain targeting peptide (mApoE). Intratracheally instilled SLN‐mApoE translocate from the lungs to the brain crossing the blood‐brain barrier. Figure. No caption available.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jconrel.2017.01.039

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 165

Metadata

Authors
Dal Magro, R., Ornaghi, F., Cambianica, I., Beretta, S., Re, F., Musicanti, C., Rigolio, R., Donzelli, E., Canta, A., Ballarini, E., Cavaletti, G., Gasco, P., & Sancini, G.
Venue
Journal of Controlled Release
Publisher
Elsevier BV
Published
2017-03
Volume
249
Pages
103-110
ISSN
0168-3659 (ISSN-L)
OpenAlex
W2581117202
Cited by
165
References
7
FWCI
4.40
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier. https://app.cochat.ai/papers/10.1016/j.jconrel.2017.01.039
The paper
Dal Magro, R., Ornaghi, F., Cambianica, I., Beretta, S., Re, F., Musicanti, C., Rigolio, R., Donzelli, E., Canta, A., Ballarini, E., Cavaletti, G., Gasco, P., & Sancini, G. (2017). ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2017.01.039

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.